Drug class
Gamma-aminobutyric acid (GABA)-A receptor positive modulator of the imidazopyridine class. Schedule IV controlled substance.
Uses
Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
Warnings
BOXED WARNING: "Complex sleep behaviors including sleep-walking, sleep-driving, and engaging in other activities while not fully awake may occur following use of zolpidem tartrate tablets. Some of these events may result in serious injuries, including death." | CNS depressant effects with next-day impairment risks; severe anaphylactic/anaphylactoid reactions possible; abnormal thinking and behavioral changes reported; respiratory depression risk, particularly with opioid use; withdrawal symptoms with rapid discontinuation; hepatic encephalopathy risk in severe liver disease.
Side effects
Short-term (under 10 nights): "Drowsiness (reported by 2% of zolpidem patients), dizziness (1%), and diarrhea (1%)." Long-term (28-35 nights): "Dizziness (5%) and drugged feelings (3%)."
